By comparing the transcription levels of SOX B1 in pan‐cancer through ONCOMINE and GEPIA data sets, SOX2 was overexpressed in GBM and LGG and SOX3 had elevated expression in LGG. The gene discussed is SOX2; the disease is cancer.